Literature DB >> 11103441

[Reactivation of herpes virus infections by vaccination: evidence or coincidence?].

R Walter1, K Hartmann, V Pool, P Gargiullo, M Kuhn.   

Abstract

Varicella zoster and herpes simplex viruses cause latent infections by persisting in human cells. Reactivation has been associated with increasing age, immunosuppression, cancer, stress, fever, exposure to ultraviolet light, and tissue damage. Based on three cases reported to the Swiss Drug Monitoring Centre SANZ, we postulated previously that vaccinations may trigger reactivation of herpes virus infections due to vaccine-induced immunomodulation. In the meantime, 10 new cases of reactivated herpes virus infections soon after vaccinations have been reported. They involved 5 women and 5 men with an age range between 16 and 60. In only one case had a trauma preceded, otherwise healthy subjects with no known relevant comorbidity were vaccinated. The clustering of reports after publication points to a previous underreporting of similar cases. This may be explained by the fact that both vaccinations and reactivations of herpes virus infections are frequent, and a causal link is not suspected. However, these new cases do not prove causality, and extensive epidemiological or experimental studies are needed to elucidate the possible link between vaccination and reactivation of herpes virus infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103441

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  3 in total

1.  Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine.

Authors:  I Tessas; N Kluger
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-11       Impact factor: 9.228

2.  Herpes Zoster Following Covaxin Receipt.

Authors:  Oumer Abdu Muhie; Haylemariam Adera; Eyob Tsige; Aschalew Afework
Journal:  Int Med Case Rep J       Date:  2021-12-01

3.  Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination.

Authors:  Nawaf Almutairi; Abdulrahman N Almutairi; Moneerah Almazyad; Sabika Alwazzan
Journal:  Dermatol Ther       Date:  2022-04-29       Impact factor: 3.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.